Sentinel lymph node identification in breast cancer: A comparison study of deep versus superficial injection of radiopharmaceutical

Nuclear Medicine Communications

Volumn 30, Issue 7, 2009, Pages 525-532

  Clímaco, Flávia ^a,b   Coelho Oliveira, Afrĝnio ^a   Djahjah, Maria Célia ^a   Gutfilen, Bianca ^a   Correia, Ana Helena Pereira ^a   Noé, Rosĝngela ^a   Da Fonseca, Lea Mirian Barbosa ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b NONE   (Brazil)

Author keywords

Breast cancer; Internal mammary nodes; Lymphatic mapping; Lymphoscintigraphy; Sentinel lymph node biopsy

Indexed keywords

DEXTRAN 500 TC 99M; EOSIN; HEMATOXYLIN; PHYTATE TC 99M; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CARCINOMA; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOLOGY; HUMAN; HUMAN TISSUE; INJECTION; MALE; SENTINEL LYMPH NODE; STAINING;

ADULT; AGED; BREAST NEOPLASMS; DEXTRANS; FEMALE; HUMANS; INJECTIONS; LYMPH NODES; MALE; MIDDLE AGED; ORGANOTECHNETIUM COMPOUNDS; PREGNANCY; RADIOPHARMACEUTICALS; SENTINEL LYMPH NODE BIOPSY;

EID: 67650324023     PISSN: 01433636     EISSN: None     Source Type: Journal    
DOI: 10.1097/MNM.0b013e32832cc25b     Document Type: Article

References (53)

1. Krag DN, Weaver DL, Alex JC, Fairbank JT. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 1993; 2:335-340.
2. Giuliano A, Jones RC, Brennan M, Statman R. Sentinel lymphadenectomy in breast cancer. J Clin Oncol 1997; 15:2345-2350.
3. Albertini JJ, Lyman GH, Cox C, Yeatman T, Balducci L, Ku N, et al. Lymphatic mapping and sentinel node biopsy on the patient with breast cancer. JAMA 1996; 276:1818-1822.
4. Krag D, Weaver D, Ashikaga T, Moffat F, Klimberg VS, Shriver C, et al. The sentinel node in breast cancer - a multicenter validation study. N Engl J Med 1998; 339:941-946.
5. Estourgie SH, Tanis PJ, Nieweg OE, Váldes Olmos RA, Rutgers EJ, Kroon BB. Should the hunt for internal mammary chain sentinel nodes begin? An evaluation of 150 breast cancer patients. Ann Surg Oncol 2003; 10:935-941.
6. Madsen E, Gobardhan P, Bongers V, Albregts M, Burgmans J, De Hooge P, et al. The impact on post-surgical treatment of sentinel lymph node biopsy of internal mammary lymph nodes in patients with breast cancer. Ann Surg Oncol 2007; 14:1486-1492.
7. Naik AM, Fey J, Gemignani M, Heerdt A, Montgomery L, Petrek J, et al. The risk of axillary relapse after sentinel lymph node biopsy for breast cancer is comparable with that of axillary lymph node dissection: a follow-up study of 4008 procedures. Ann Surg 2004; 240:462-471.
8. Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V, et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 2003; 349:546-553.
9. Posther KE, McCall LM, Blumencranz PW, Burak WE Jr, Beitsch PD, Hansen NM, et al. Sentinel node skills verification and surgeon performance: data from a multicenter clinical trial for early-stage breast cancer. Ann Surg 2005; 242:593-599.
10. Zavagno G, Rubello D, Franchini Z, Meggiolaro F, Ballarin A, Casara D, et al. Axillary sentinel lymph nodes in breast cancer: a single lymphatic pathway drains the entire mammary gland. Eur J Surg Oncol 2005; 31:479-484.
11. Lin KM, Patel TH, Ray A, Ota M, Jacobs L, Kuvshinoff B, et al. Intradermal radioisotope is superior to peritumoral blue dye or radioisotope in identifying breast cancer sentinel nodes. J Am Coll Surg 2004; 199:561-566.
12. Pelosi E, Bellò M, Giors M, Ala A, Giani R, Bussone R, et al. Sentinel lymph node detection in patients with early-stage breast cancer: comparison of periareolar and subdermal/peritumoral injection techniques. J Nucl Med 2004; 45:220-225.
13. McMasters KM, Wong SL, Martin RC 2nd, Chao C, Tuttle TM, Noyes RD, et al. Dermal injection of radiactive colloid is superior to peritumoral injection for breast cancer sentinel lymph node biopsy: results of a multiinstitutional study. Ann Surg 2001; 233:676-687.
14. Koizumi M, Koyama M, Yamashita T, Tada K, Nishimura S, Takahashi K, et al. Experience with intradermal injection and intradermal-plus-deep injection in the radioguided sentinel node biopsy of early breast cancer patients. Eur J Surg Oncol 2006; 32:738-742.
15. Povoski SP, Olsen JO, Young DC, Clarke J, Burak WE, Walker MJ, et al. Prospective randomized clinical trial comparing intradermal, intraparenchymal, and subareolar injection routes for sentinel lymph node mapping and biopsy in breast cancer. Ann Surg Oncol 2006; 13:1412-1421.
16. Maza S, Valencia R, Gerworski L, Zander A, Guski H, Winzer KJ, et al. Peritumoral versus subareolar administration of technetium-99m nanocolloid for sentinel lymph node detection in breast cancer: preliminary results of a prospective intra-individual comparative study. Eur J Nucl Med Mol Imaging 2003; 30:651-656.
17. Carcoforo P, Sortini D, Feggi L, Feo CV, Soliani G, Panareo S, et al. Clinical and therapeutic importance of sentinel node biopsy of the internal mammary chain in patients with breast cancer: a single-center study with long-term follow-up. Ann Surg Oncol 2006; 13:1338-1343.
18. Shimazu K, Tamaki Y, Taguchi T, Motomura K, Inaji H, Koyama H, et al. Lymphoscintigraphic visualization of internal mammary nodes with subtumoral injection of radiocolloid in patients with breast cancer. Ann Surg 2003; 237:390-398.
19. Mudun A, Sanli Y, Ozmen V, Turkmen C, Ozel S, Eroglu A, et al. Comparison of different injection sites of radionuclide for sentinel lymph node detection in breast cancer: single institution experience. Clin Nucl Med 2008; 33:262-267.
20. Sanli Y, Berberoglu K, Turkmen C, Ozmen V, Muslumanoglu M, Igci A, et al. The value of combined peritumoral and subdermal injection techniques for lymphoscintigraphy in detection of sentinel lymph node in breast cancer. Clin Nucl Med 2006; 31:690-693.
21. Dede F, Gulluoglu BM, Ones T, Farsakoglu Z, Calskan B, Mems H, et al. Multiparametric analysis of preoperative lymphatic mapping with the use of combined deep plus superficial radiotracer injection technique in early breast cancer. Nucl Med Commun 2008; 29:546-552.
22. Coelho-Oliveira A, Gutfilen B, Chagas CR, Lopes de Souza SA, Pinheiro Pessoa MC, Barbosa da Fonseca LM. Identification of sentinel node in breast cancer: comparison between peritumoral and periareolar injection of the radiopharmaceutical contrast medium. J Exp Clin Cancer Res 2004; 23:567-572.
23. Freedman GM, Fowble BL, Nicolau N, Sigurdson ER, Torosian MH, Boraas MC, et al. Should internal mammary lymph nodes in breast cancer be a target for the radiation oncologist? Int J Rad Oncol Biol Phys 2000; 46:805-814.
24. Tanis PJ, Nieweg OE, Valdés Olmos RA, Kroon BB. Anatomy and physiology of lymphatic drainage of the breast from the perspective of sentinel node biopsy. J Am Coll Surg 2001; 192:399-409.
25. Mariani G, Moresco L, Viale G, Villa G, Bagnasco M, Canavese G, et al. Radioguided sentinel lymph node biopsy in breast cancer surgery. J Nucl Med 2001; 42:1198-1215.
26. Eroglu A, Mudun A, Berberoglu K, Asoglu O, Ozmen V, Muslumanoglu M, et al. Comparison of subdermal and peritumoral injection techniques of lymphoscintigraphy to determine the sentinel lymph node in breast cancer. Clin Nucl Med 2004; 29:306-311.
27. Bauer TW, Spitz FR, Callans LS, Alavi A, Mick R, Weinstein SP, et al. Subareolar and peritumoral injection identify similar sentinel nodes for breast cancer. Ann Surg Oncol 2002; 9:169-176.
28. Yu J, Li G, Li J, Wang Y. The pattern of lymphatic metastasis of breast cancer and its influence on the delineation of radiation fields. Int J Radiat Oncol Biol Phys 2005; 61:874-878.
29. Paredes P, Vidal-Sicart S, Zanón G, Pahisa J, Fernández PL, Velasco M, et al. Clinical relevance of sentinel lymph nodes in the internal mammary chain in breast cancer patients. Eur J Nucl Med Mol Imaging 2005; 32:1283-1287.
30. Van Rijk MC, Tanis PJ, Nieweg OE, Olmos RA, Rutgers EJ, Hoefnagel CA, Kroon BB. Clinical implications of sentinel nodes outside the axilla and internal mammary chain in patients with breast cancer. J Surg Oncol 2006; 94:281-286.
31. De Cicco C, Cremonesi M, Luini A, Bartolomei M, Grana C, Prisco G, et al. Lymphoscintigraphy and radioguided biopsy of the sentinel axillary node in breast cancer. J Nucl Med 1998; 39:1080-1084.
32. Babiera GV, Delpassand ES, Breslin TM, Ross MI, Ames FC, Singletary SE, et al. Lymphatic drainage patterns on early versus delayed breast lymphoscintigraphy performed after injection of filtered Tc-99m sulfur colloid in breast cancer patients undergoing sentinel lymph node biopsy. Clin Nucl Med 2005; 30:11-15.
33. Upponi SS, McIntosh SA, Wishart GC, Balan KK, Purushotham AD. Sentinel lymph node biopsy in breast cancer - is lymphoscintigraphy really necessary? Eur J Surg Oncol 2002; 28:479-480.
34. Dupont EL, Kamath VJ, Ramnath EM, Shivers SC, Cox C, Berman C, et al. The role of lymphoscintigraphy in the management of the patient with breast cancer. Ann Surg Oncol 2001; 8:354-360.
35. McMasters KM, Wong SL, Tuttle TM, Carlson DJ, Brown CM, Dirk Noyes R, et al. Preoperative lymphoscintigraphy for breast cancer does not improve the ability to identify axillary sentinel lymph nodes. Ann Surg 2000; 231:724-731.
36. Kawase K, Gayed IW, Hunt KK, Kuerer HM, Akins J, Yi M, et al. Use of lymphoscintigraphy defines lymphatic drainage patterns before sentinel lymph node biopsy for breast cancer. J Am Coll Surg 2006; 203:64-72.
37. Uren RF, Howman-Giles RB, Thompson JF, Malouf D, Ramsey-Stewart G, Niesche FW, et al. Mammary lymphoscintigraphy in breast cancer. J Nucl Med 1995; 36:1775-1780.
38. Yeung HW, Cody HS III, Turlakow A, Riedel ER, Fey J, Gonen M, et al. Lymphoscintigraphy and sentinel node localization in breast cancer patients: a comparison between 1-day and 2-day protocols. J Nucl Med 2001; 42:420-423.
39. McCarter MD, Yeung H, Yeh S, Fey J, Borgen PI, Cody HS 3rd. Localization of the sentinel node in breast cancer: identical results with same-day and day-before isotope injection. Ann Surg Oncol 2001; 8:682-686.
40. Farrús B, Vidal-Sicart S, Velasco M, Zanón G, Fernández PL, Muñoz M, et al. Incidence of internal mammary node metastases after a sentinel lymph node technique in breast cancer and its implication in the radiotherapy plan. Int J Radiat Oncol Biol Phys 2004; 60:715-721.
41. Roumen RMH, Valkenburg JGM, Geuskens LM. Lymphoscintigraphy ans feasibility of sentinel node biopsy in 83 patients with prymary breast cancer. Eur J Surg Oncol 1997; 23:495-502.
42. Pritsivelis C, Garcia Mendonça CA, Pinheiro Pessoa MC, Coelho-Oliveira A, Gutfilen B, Barbosa da Fonseca LM. Failure predictors of the sentinel lymph node in patients with breast cancer using Tc-99m sulfur colloid and periareolar injection. Q J Nucl Med Mol Imaging 2007; 51:189-193.
43. Kesmodel SB, Canter RJ, Terhune KP, Bauer TW, Mick R, Rosato EF, et al. Use of radiotracer for sentinel lymph node mapping in breast cancer optimizes staging independent of site of administration. Clin Nucl Med 2006; 31:527-533.
44. Dupont E, Cox CE, Nguyen K, Salud CJ, Peltz ES, Whitehead GF, et al. Utility of internal mammary lymph node removal when noted by intraoperative gamma probe detection. Ann Surg Oncol 2001; 8:833-836.
45. Estourgie SH, Nieweg OE, Olmos RA, Rutgers EJ, Kroon BB. Lymphatic drainage patterns from the breast. Ann Surg 2004; 239:232-237.
46. Van der Ent FW, Kengen RA, van der Pol HA, Povel JA, Stroeken HJ, Hoofwijk AG. Halsted revisited: internal mammary sentinel lymph node biopsy in breast cancer. Ann Surg 2001; 234:79-84.
47. Byrd DR, Dunnwald LK, Mankoff DA, Anderson BO, Moe RE, Yeung RS, et al. Internal mammary lymph node drainage patterns in patients with breast cancer documented by breast lymphoscintigraphy. Ann Surg Oncol 2001; 8:234-240.
48. Lyman GH, Giuliano AE, Somerfield MR, Benson AB III, Bodurka DC, Burstein HJ, et al. American Society of clinical oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 2005; 23:7703-7720.
49. Bevilacqua JL, Gucciardo G, Cody HS, MacDonald KA, Sacchini V, Borgen PI, et al. A selection algorithm for internal mammary sentinel lymph node biopsy in breast cancer. Eur J Surg Oncol 2002; 28:603-614.
50. Treseler P. Pathologic examination of the sentinel lymph node: what is the best method? Breast J 2006; 12 (5 Suppl 2):S143-S151.
51. Herbert GS, Sohn VY, Brown TA. The impact of nodal isolated tumor cells on survival of breast cancer patients. Am J Surg 2007; 193:571-574.
52. Rydén L, Chebil G, Sjö ström L, Pawlowski R, Jönsson P-E. Determination of sentinel lymph node (SLN) status in primary breast cancer by prospective use of immunohistochemistry increases the rate of micrometastases and isolated tumour cells: analysis of 174 patients after SLN biopsy. Eur J Surg Oncol 2007; 33:33-38.
53. Layeeque R, Kepple J, Henry-Tillman RS, Adkins L, Kass R, Colvert M, et al. Intraoperative subareolar radioisotope injection for immediate sentinel lymph node biopsy. Ann Surg 2004; 239:841-845.